August Therapeutics
Dr. Mark Sullivan holds undergraduate degrees in microbiology and molecular biology through Washington State University and advanced degrees of Doctor of Medicine and Master of Public Health both through the University of Washington. He is a board-certified physician in three specialties of Internal Medicine, Critical Care Medicine, and Occupational/Environmental Medicine with a special interest in toxic exposure assessment and treatment. Dr. Sullivan completed his MPH research thesis on the association between transition metal components of < 2.5-micron particulate matter (PM 2.5) and lung function and density as potentially relates to chronic obstructive pulmonary disease (COPD) prevalence. Past research experience includes identifying the structure of the working genome of the Human Foamy Retrovirus at Fred Hutchinson Cancer Research Center and helping to identify the Alzheimer’s and Werner’s disease gene locus at the University of Washington.
This person is not in the org chart
This person is not in any offices
August Therapeutics
August Therapeutics is working to solve complex problems in taste receptor biology and employ new therapeutic modalities to treating eating disorders and obesity.